| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | 0.78 | 0.002 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.088 | 0.005 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.17 | 0.005 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.099 | 0.006 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.096 | 0.007 |
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | 0.092 | 0.01 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.01 |